Unichem Laboratories informs about press release

07 Jul 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it has enclosed a press release on 7th July 2020, pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, 7.5 mg and 10 mg.

The above information is a part of company’s filings submitted to BSE.


Unichem Lab Share Price

724.60 16.50 (2.33%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.